NEWS
Hippocampus in the brain’s temporal lobe involved in quick, successful conflict resolution
The hippocampus in the brain's temporal lobe is responsible for more than just long-term memory. Researchers have for the first time demonstrated that it is also involved in quick and successful conflict resolution. The team headed by Prof Dr Nikolai Axmacher from the...
Aeolus Announces Publication of Study Showing AEOL 10150 Improves Memory and Protects Brain Damage in an Animal Model of Epilepsy
Aeolus Pharmaceuticals, Inc. a biotechnology company developing compounds to protect against radiological and chemical threats, announced the publication of a study in mice demonstrating that treatment with their AEOL 10150 significantly improved memory and decreased...
A New Study Analyzes First Year Treatment Costs of Pediatric Epilepsy
First year treatment costs were found to be substantial. Average cost of $20k per child with epilepsy in first year after diagnoses. Improving seizure control could reduce costs dramatically. Targeting and Improving quality of life issues could also reduce cost....
Scientists Uncover a Difference Between the Sexes
Sex does matter: key molecular process in brain is different in males and females? EVANSTON, Ill. --- Male and female brains operate differently at a molecular level, a Northwestern University research team reports in a new study of a brain region involved in learning...
Music Therapy May Hold Promise For Treating Epilepsy
We know that listening to classical music can lower blood pressure, reduce stress levels and even boost learning. But could it also help prevent seizures in people with epilepsy? Now that neurologists have found that the brains of people with epilepsy process music...
UNC researchers show how a genetic mutation disables molecular switch and causes autism
Last December, researchers identified more than 1,000 gene mutations in individuals with autism, but how these mutations increased risk for autism was unclear. Now, UNC School of Medicine researchers are the first to show how one of these mutations disables a...
CBD for Infantile Spasms Given OK by The FDA
Insys Therapeutics, Inc. (NASDAQ: INSY) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its pharmaceutical cannabidiol (CBD) candidate for the treatment of infantile spasms (IS). "We are pleased to have received...
FDA Approves 1st 3d Printed Drug, and it is For Epilepsy
The US Food and Drug Administration (FDA) has approved the first three-dimensional printed oral drug product, Spritam(levetiracetam), from Aprecia Pharmaceuticals, the company announced today. Levetiracetam is indicated as adjunctive therapy for partial-onset...
Migraine Ups Stroke Risk, but Only in Smokers
Migraine is associated with an increased risk for stroke among active smokers, but not nonsmokers, new research shows. The findings, from a population-based multiethnic cohort study of stroke incidence, were published online July 22 in Neurology by Teshamae S....
Study finds girls with mild autism susceptible to treatment-resistant epilepsy
New York — In a study published in the June issue of Autism Research, researchers at the New York University observed that girls with mild autism are susceptible to what scientists call ‘treatment-resistant’ epilepsy. It has long been observed by researchers that...
Epilepsy: New Data on Focal Seizures
Patients with idiopathic generalized epilepsies (IGE) can also have focal seizure symptoms. A team of Australian researchers has added some findings that indicate which patients are more likely to have both types of seizures. Focal seizure symptoms (FSS) occur equally...
Midazolam Nasal Spray May Reduce Seizures
A nasal spray formulation of midazolam may diminish repeated seizures and lower the risk of generalized tonic-clonic seizures in hospitalized epilepsy patients, researchers found. In a retrospective analysis of data from a German university epilepsy center, those...
New FDA-Approved Device For Treatment Of Drug-Resistant Epilepsy Now Offering Hope To Patients In U.S.
In just one month following FDA approval of the AspireSR® generator for the VNS Therapy® System, leading hospitals across approximately 40 states have begun providing this new treatment option for patients with drug-resistant epilepsy. As many as one third of people...
Couple thrilled by daughter’s early response to medical marijuana
It’s early days, but a Hibbing couple are ecstatic about their daughter’s initial response to treatment with medical marijuana. “We gave her her first dose on Friday morning,” Angie Weaver said on Monday about 9-year-old daughter Amelia. “She had a seizure-free day.”...
Epilepsy: New Data on Focal Seizures
Patients with idiopathic generalized epilepsies (IGE) can also have focal seizure symptoms. A team of Australian researchers has added some findings that indicate which patients are more likely to have both types of seizures. Focal seizure symptoms (FSS) occur equally...
Study suggests potential way to predict autism or psychosis risk in children with genetic abnormality
Doctors and researchers have long known that children who are missing about 60 genes on a certain chromosome are at a significantly elevated risk for developing either a disorder on the autism spectrum or psychosis — that is, any mental disorder characterized by...
Girls with mild autism prone to severe epilepsy
Girls with autism are nearly three times as likely as boys with the disorder to have severe epilepsy that responds poorly to medication1. The findings, published 26 June in Autism Research, add a twist to one of the biggest conundrums in autism: its 4-to-1 ratio of...
New research shows concussion may affect men and women differently
New research suggests concussion may not significantly impair symptoms or cognitive skills for one gender over another, however, women may still experience greater symptoms and poorer cognitive performance at preseason testing. The study released today will be...
Focal symptoms may be prognostic in generalised epilepsies
By Eleanor McDermid, Senior medwireNews Reporter Symptoms consistent with focal seizures are often reported by patients who have idiopathic generalized epilepsies (IGE) and are associated with a short duration of freedom from seizures, say researchers. This strong...
Children recover well from acute central nervous system demyelination
Most children can expect a good and quick physical recovery following acute central nervous system demyelination, study findings suggest. Although a serious illness, which resulted in 86% of the 283 children studied being hospitalised for 3 to 10 days, 254 (90%) of...
